| Ytd | -96.48% | |
| 1y | -98.48% |
| Open | Prev Close | 15.68 | Low | High | Mkt Cap | 2.34M | |||
| Vol | 0.00 | Avg Vol | 943.70K | EPS | -830.44 | P/E | -0.00 | Forward P/E | -11.83 |
| Beta | 1.16 | Short Ratio | 0.22 | Inst. Own | 1.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 10.51 | 200-d Avg | 187.03 | 1yr Est | 0.00 |
RSLS News
“From 2019 to 2025, the biomarker landscape has seen a surge in strategic collaborations, licensing,
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $HIND--Vyome Therapeutics, Inc. (“Vyome”), a clinical-stage he
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $HIND--Vyome Therapeutics, Inc., a clinical-stage healthcare c
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Therapeutics, Inc., a clinical-stage healthcare company tar
IRVINE, Calif.--(BUSINESS WIRE)---- $HIND--ReShape Lifesciences® (Nasdaq: RSLS) announced today that
Partial Adjournment for Proposal 2, Asset Sale Proposal, and Proposal 3, Charter Amendment Proposal;
Company to Host Pre-Eminent Lap-Band® Surgeon Advocates For a Three-Day Seminar, August 1-3, 2025 Co
Board of Directors Unanimously Recommend Approving Merger Agreement With Vyome Therapeutics and Asse
Patent Enhances and Broadens the Company's Intellectual Property Portfolio Around a Swallowable and
IRVINE, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the prem
Reduction in Force Estimated to Save Over $750K or 23.4% of Annual Payroll Expenses Agreements Progr
Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia Vagal Neu
Recon Supply Named Exclusive U.S. Distributor of ReShape's STIMEL-03, Lap-Band® 2.0 FLEX, and Full P
IRVINE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (“ReShape” or the “Company
IRVINE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (Nasdaq: RSLS), the premier
IRVINE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premi
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 700 points on Mo
IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premi
Vagal Neuromodulation Offers a Novel Approach to Treating Diabetes and Hypoglycemia Device Demonstra
Patent Expands and Strengthens Intellectual Property Portfolio Around a Swallowable and Degradable I
During the session on Thursday, 461 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings f
On Thursday, 588 stocks hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
On Thursday, 105 stocks hit new 52-week lows.
Stocks Which Set New 52-Week Low Yesterday, October 9th